[Japon] Can Japan bridge the vaccine divide?

Auteur : Shihoko Goto. Contributing writer of The Japan Times. Shihoko Goto is deputy director for geoeconomics with the Wilson Center’s Asia Program based in Washington.

Production : The Japan Times

Diffusion : site de The Japan Times

Date : 18 novembre 2020

As winter approaches and colder weather makes it even more difficult to adhere to social distancing measures, the odds of COVID-19 spreading still further seem to be inevitable. Still, despite having the highest infection rate in the world, there is growing optimism in the United States, thanks to the prospect of effective vaccines being developed in the not-too-distant future. The fact that financial markets worldwide have also welcomed the latest news from Pfizer and Moderna on their respective developments for fighting the virus also demonstrates continued global confidence in U.S. scientific research.

Source : Shihoko Goto, « Can Japan bridge the vaccine divide? », The Japan Times, 18/11/2020. URL : https://www.japantimes.co.jp/opinion/2020/11/18/commentary/japan-commentary/japan-coronavirus-vaccine-divide/ (consulté le 18/11/2020)

Photo « à la une » : Japan too has been developing its own drug, Avigan, against COVID-19. Yet the drug being developed by Fujifilm is not a vaccine but rather a treatment for coronavirus symptoms. © BLOOMBERG


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Ce site utilise Akismet pour réduire les indésirables. En savoir plus sur comment les données de vos commentaires sont utilisées.

Rechercher dans OpenEdition Search

Vous allez être redirigé vers OpenEdition Search